Autologous Correction of Primary Immunodeficiency Diseases
Monday, March 7, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Troy R. Torgerson , MD PhD

Learning Objectives:
  1. Discuss current progress in gene therapy trials for primary immunodeficiency diseases
  2. Discuss potential uses of induced pluripotent stem cells for both diagnosis and treatment of primary immunodeficiency diseases
  3. Describe the Cas9/CRISPR system and potential methods for site-specific correction of genetic defects in autologous cells
5:00 PM
Question & Answer
5:10 PM
Potential Applications for Induced-Pluripotent Stem Cells
Katja G. Weinacht, MD PhD
5:25 PM
Question & Answer
5:35 PM
Novel Tools for Gene Editing
Caroline Y. Kuo, MD
5:50 PM
Question & Answer
See more of: Session